Answers are grounded in this paper and cite their sources.
The re-uptake of neurotransmitters into the nerve terminal terminates synaptic transmission at most central synapses and constitutes a key step in the modulation of synaptic efficacy. Recently, the cloning of several Na(+)-driven neurotransmitter transporters has resulted in the description of a novel family of homologous membrane proteins, each with 12 transmembrane segments. These transporters constitute major targets of widely used drugs, and modulation of transporter gene expression and/or activity may represent an important substrate for plasticity in the nervous system.
No takes yet. Share an insight, caveat, or question.
Schloss et al. (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: